US biotech firm OrthoPediatrics acquires Trendlines portfolio firm ApiFix

Nasdaq-listed bio-science company OrthoPediatrics has acquired ApiFix, a portfolio company of Singapore-listed Trendlines, for $2 million in cash and nearly 1 million shares of the company’s common stock, according to an announcement.

OrthoPediatrics, a company focused on advancing the field of pediatric orthopaedics, said the acquisition includes ApiFix’s minimally invasive deformity correction system for non-fusion treatment of progressive idiopathic scoliosis.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter